Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Prasse (Hannover, Germany). Gender associated Differences in Patients with IPF based on the Analysis of the INSIGHTS-IPF Registry Data. 4637

Member's Comments

No comment yet.

Related content which might interest you: The phenotype of the Adult Mexican Patient with Pulmonary Arterial Hypertension: Baseline characteristics of the REMEHIP Registry. The REMEHIP Investigators. Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Spectrum of pulmonary Parametric Response Maps in Asthmatic patients: defining asthma subtypes Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Baseline characteristics of 1461 participants in the Pulmonary Fibrosis Foundation Patient Registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Clinical Analysis of Pathologically Diagnosed Cryptogenic Organizing Pheumonia:A 14-year Retrospective Analysis of 176 COP Patients. Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Prediction of IPF Progression Using HRCT Imaging Patterns in Elderly Population Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 The Importance of Mean Platelet Volume in Evaluating Cardiovascular Diseasesamong Patients with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017 Airway clearance techniques in patients with bronchiectasis. Data from the EMBARC Registry. Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 PP305 – Can Hematological Ratios Predict Outcome of COVID-19 Patients? Egyptian Multicentric Study Source: ERS Lung Science Conference 2021 Year: 2021 Sex Differences in Severe Asthma Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 A Novel Big Data Analysis of Longitudinal CPAP Compliance Patterns Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 What are the determinants in Patient Activation Scores in COPD? Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Google Trend Data Analysis of COVID-19 Repercussion on Lung Cancer Awareness in Italy Source: Virtual Congress 2021 – Thoracic surgery, lung cancer and complications of COVID-19 Year: 2021 Association between Metabolites Biomarkers and Pulmonary Hypertension:A Mendelian Randomization analysis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk Score for Subclinical COPD: The NHLBI Pooled Cohorts Study Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Data Sharing Agreement Source: Global Lung Function Initiative Year: 2017